Cancer Control Within Reach? Only If It’s Profitable!

Cancer Control Within Reach? Only If It’s Profitable!

Promising studies are lacking follow-up and funding. The problem? The solutions are too cheap! One such potential treatment is an experimental, synthetic cancer drug—DCA (dichloroacetate)—which has, in the early stages of clinical trials, demonstrated effectiveness at fighting cancer. The drug seems to exhibit antitumor effects against several forms of cancer, including brain, cervical, prostate, breast, […]

Read More